Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherSpecial Contribution

18F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval

Hong Song, Andrei Iagaru and Steven P. Rowe
Journal of Nuclear Medicine September 2021, jnumed.121.262989; DOI: https://doi.org/10.2967/jnumed.121.262989
Hong Song
1 Stanford University, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Iagaru
1 Stanford University, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrei Iagaru
Steven P. Rowe
2 Johns Hopkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.121.262989
DOI 
https://doi.org/10.2967/jnumed.121.262989
PubMed 
34531266

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online September 16, 2021.

Article Versions

  • You are currently viewing a previous version of this article (September 16, 2021 - 04:58).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Hong Song1,
  2. Andrei Iagaru1 and
  3. Steven P. Rowe2
  1. 1 Stanford University, United States;
  2. 2 Johns Hopkins
  1. For correspondence or reprints contact: Andrei Iagaru, Stanford University, 300 Pasteur Dr, H2200, Stanford, California 94305, United States. E-mail: aiagaru@stanford.edu

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • Google Scholar

Article usage

Article usage: September 2021 to June 2022

AbstractFullPdf
Sep 20211769088
Oct 2021950060
Nov 2021425058
Dec 2021367065
Jan 2022295092
Feb 2022167034
Mar 2022137018
Apr 2022116069
May 202275034
Jun 20227817219
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (7)
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval
Hong Song, Andrei Iagaru, Steven P. Rowe
Journal of Nuclear Medicine Sep 2021, jnumed.121.262989; DOI: 10.2967/jnumed.121.262989

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval
Hong Song, Andrei Iagaru, Steven P. Rowe
Journal of Nuclear Medicine Sep 2021, jnumed.121.262989; DOI: 10.2967/jnumed.121.262989
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Special Contribution

  • Female Authors in Nuclear Medicine Journals: A Survey from 2014 to 2020
  • Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Show more Special Contribution

Clinical (Oncology: GU)

  • Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT for characterization of solid renal masses
  • The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients
  • Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Oncology: GU
  • PET
  • radiopharmaceuticals
  • 18F DCFPyL
  • prostate cancer
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire